HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Alberto Mantovani Selected Research

Fibrosarcoma

10/2021Tumor-Released Products Promote Bone Marrow-Derived Macrophage Survival and Proliferation.
1/2021Intratumoral combination therapy with poly(I:C) and resiquimod synergistically triggers tumor-associated macrophages for effective systemic antitumoral immunity.
12/2006p50 nuclear factor-kappaB overexpression in tumor-associated macrophages inhibits M1 inflammatory responses and antitumor resistance.
3/2006A distinct and unique transcriptional program expressed by tumor-associated macrophages (defective NF-kappaB and enhanced IRF-3/STAT1 activation).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Alberto Mantovani Research Topics

Disease

135Inflammation (Inflammations)
11/2023 - 05/2002
113Neoplasms (Cancer)
02/2024 - 07/2002
36Infections
11/2023 - 10/2002
24COVID-19
02/2023 - 01/2021
18Neoplasm Metastasis (Metastasis)
05/2023 - 07/2002
14Carcinogenesis
02/2024 - 07/2007
8Body Weight (Weight, Body)
01/2022 - 09/2014
7Adenocarcinoma
04/2024 - 11/2004
7Sepsis (Septicemia)
01/2022 - 10/2002
7Fibrosis (Cirrhosis)
01/2021 - 04/2011
7Cardiovascular Diseases (Cardiovascular Disease)
01/2020 - 05/2002
7Myocardial Infarction
01/2012 - 07/2004
6Pneumonia (Pneumonitis)
10/2022 - 10/2010
6Heart Failure
07/2022 - 10/2004
6Fever (Fevers)
03/2022 - 08/2007
5Colitis
02/2024 - 02/2010
5Melanoma (Melanoma, Malignant)
01/2023 - 07/2006
5Pancreatic Neoplasms (Pancreatic Cancer)
05/2022 - 11/2004
5Rheumatoid Arthritis
01/2021 - 06/2007
5Obesity
11/2019 - 05/2003
5Thrombosis (Thrombus)
01/2017 - 05/2002
5Hypoxia (Hypoxemia)
02/2013 - 07/2002
4Post-Acute COVID-19 Syndrome
11/2023 - 01/2022
4Lung Neoplasms (Lung Cancer)
01/2023 - 02/2016
4Atherosclerosis
10/2022 - 07/2004
4Fibrosarcoma
10/2021 - 03/2006
4Sarcoma (Soft Tissue Sarcoma)
01/2021 - 03/2006
4Giant Cell Arteritis (Horton Disease)
03/2020 - 01/2012
4Systemic Lupus Erythematosus (Libman-Sacks Disease)
01/2019 - 06/2002
4Colorectal Neoplasms (Colorectal Cancer)
07/2018 - 04/2014
4Coccidiosis
07/2018 - 12/2017
4Colonic Neoplasms (Colon Cancer)
08/2016 - 01/2009
4Acquired Immunodeficiency Syndrome (AIDS)
03/2016 - 07/2008
4Necrosis
11/2015 - 06/2003
4Acute-Phase Reaction
01/2012 - 08/2004
3Osteoarthritis
01/2023 - 11/2011
3Hypersensitivity (Allergy)
11/2022 - 01/2005
3Shock
01/2022 - 01/2009
3Bacterial Infections (Bacterial Infection)
01/2021 - 08/2005
3Takayasu Arteritis (Arteritis, Takayasu's)
03/2020 - 11/2014
3Heart Diseases (Heart Disease)
01/2020 - 02/2008
3Lung Injury
01/2020 - 08/2008
3Congenital Abnormalities (Deformity)
11/2019 - 07/2007
3Septic Shock (Toxic Shock Syndrome)
01/2017 - 07/2004

Drug/Important Bio-Agent (IBA)

52PTX3 proteinIBA
11/2023 - 02/2003
48CytokinesIBA
10/2022 - 07/2002
45ChemokinesIBA
01/2023 - 07/2002
25Biomarkers (Surrogate Marker)IBA
12/2023 - 10/2004
24Complement System Proteins (Complement)IBA
12/2023 - 06/2002
22Proteins (Proteins, Gene)FDA Link
11/2022 - 05/2002
17AntibodiesIBA
02/2024 - 03/2010
16Pattern Recognition ReceptorsIBA
01/2021 - 07/2004
15Interleukin-1 Receptors (Interleukin 1 Receptor)IBA
01/2023 - 03/2003
14Chemokine ReceptorsIBA
01/2023 - 11/2003
14Interleukin-1 (Interleukin 1)IBA
01/2021 - 10/2002
14C-Reactive ProteinIBA
01/2017 - 05/2002
13LigandsIBA
01/2023 - 11/2003
12VaccinesIBA
11/2023 - 02/2008
11Messenger RNA (mRNA)IBA
01/2023 - 06/2007
10Toll-Like Receptors (Toll-Like Receptor)IBA
01/2023 - 08/2010
9Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
11/2023 - 05/2003
9Interleukin-6 (Interleukin 6)IBA
01/2022 - 03/2003
8Hormones (Hormone)IBA
01/2023 - 10/2002
8Antiviral Agents (Antivirals)IBA
01/2023 - 03/2008
8Acute-Phase Proteins (Acute-Phase Protein)IBA
04/2020 - 02/2003
6Immunoglobulin G (IgG)IBA
11/2022 - 01/2016
5Monoclonal AntibodiesIBA
01/2023 - 11/2004
5AutoantibodiesIBA
01/2023 - 02/2007
5RNA (Ribonucleic Acid)IBA
01/2023 - 01/2009
5LipidsIBA
07/2022 - 02/2008
5Interleukin-10 (Interleukin 10)IBA
01/2022 - 12/2006
5MicroRNAs (MicroRNA)IBA
10/2021 - 03/2009
5Scavenger Receptors (Scavenger Receptor)IBA
11/2016 - 05/2005
5Transcription Factors (Transcription Factor)IBA
08/2016 - 11/2005
4BNT162 VaccineIBA
11/2023 - 01/2022
4Environmental Pollutants (Pollutants, Environmental)IBA
10/2023 - 07/2015
4COVID-19 VaccinesIBA
01/2023 - 01/2021
4Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
10/2022 - 02/2008
4Interleukin-8 (Interleukin 8)IBA
01/2022 - 06/2009
4Testosterone (Sustanon)FDA Link
04/2021 - 03/2015
4Indicators and Reagents (Reagents)IBA
01/2021 - 08/2005
4FibrinIBA
01/2021 - 05/2002
4CC ChemokinesIBA
01/2018 - 02/2007
4Immunoglobulins (Immunoglobulin)IBA
11/2017 - 04/2010
4InterleukinsIBA
01/2017 - 10/2002
4EnzymesIBA
07/2016 - 10/2005
4Chemokine Receptor D6IBA
01/2016 - 01/2013
4TrabectedinIBA
01/2015 - 03/2010
4Oxygen (Dioxygen)IBA
02/2013 - 07/2002
3ElementsIBA
04/2024 - 10/2010
3InterferonsIBA
01/2023 - 01/2006
3Immune Checkpoint InhibitorsIBA
11/2022 - 01/2017
3Conditioned Culture MediaIBA
10/2021 - 07/2010
3Imiquimod (Aldara)FDA LinkGeneric
01/2021 - 09/2013
3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
03/2020 - 03/2010
3Interleukin-17 (Interleukin 17)IBA
01/2018 - 09/2013
3IronIBA
02/2017 - 02/2008

Therapy/Procedure

35Therapeutics
04/2024 - 04/2006
11Immunotherapy
11/2022 - 01/2015
6Drug Therapy (Chemotherapy)
01/2023 - 09/2013